Antitumour necrosis factor-α therapy modulates angiopoietin-2 serum levels in non-diabetic ankylosing spondylitis patients

Ann Rheum Dis. 2013 Jul;72(7):1265-7. doi: 10.1136/annrheumdis-2012-203169. Epub 2013 Mar 12.
No abstract available

Keywords: Ankylosing Spondylitis; Anti-TNF; Atherosclerosis; Inflammation.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiopoietin-2 / blood*
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Biomarkers / blood
  • Cohort Studies
  • Humans
  • Infliximab
  • Spondylitis, Ankylosing / blood
  • Spondylitis, Ankylosing / drug therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Angiopoietin-2
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Biomarkers
  • Tumor Necrosis Factor-alpha
  • Infliximab